https://doi.org/10.4081/monaldi.2021.1617
Single inhaler triple therapy in COPD – all that glitters is not gold
Submitted: September 22, 2020
Accepted: November 30, 2020
Published: April 28, 2021
Accepted: November 30, 2020
Abstract Views: 1175
PDF: 634
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Dear Editor,
The recent studies on combination triple therapy of inhaled corticosteroid, long acting beta2 agonist and long-acting muscarinic antagonist (ICS-LABA-LAMA) in COPD have consistently demonstrated an improvement in exacerbation frequency and/or improvement of lung function...
Lipson DA, Crim C, Criner GJ, et al. Reduction in all-cause mortality with Fluticasone furoate/Umeclidinium/Vilanterol in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2020;201:1508-16.
DOI: https://doi.org/10.1164/rccm.201911-2207OC
Casas A, Montes de Oca M, Menezes AM, et al. Respiratory medication used in COPD patients from seven latin american countries: the LASSYC study. Int J Chron Obstruct Pulmon Dis 2018;13:1545-56.
DOI: https://doi.org/10.2147/COPD.S154097
Buhl R, Criée C-P, Kardos P, et al. Patients in clinical trials on COPD triple therapy compared to real world populations Am J Respir Crit Care Med 2019;199:A1117.
DOI: https://doi.org/10.1164/ajrccm-conference.2019.199.1_MeetingAbstracts.A1117
Watz H, Tetzlaff K, Wouters EF, et al. Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial. Lancet Respir Med 2016;4:390-8.
DOI: https://doi.org/10.1016/S2213-2600(16)00100-4
Silva GE, Sherrill DL, Guerra S, Barbee RA. Asthma as a risk factor for COPD in a longitudinal study. Chest 2004;126:59-65.
DOI: https://doi.org/10.1378/chest.126.1.59
Ferguson GT, Rabe KF, Martinez FJ, et al. Triple therapy with budesonide/glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disease (KRONOS): a double-blind, parallel-group, multicentre, phase 3 randomised controlled trial. Lancet Respir Med 2018;6:747-8.
DOI: https://doi.org/10.1016/S2213-2600(18)30327-8
Palli SR, Frazer M, DuCharme M, et al. Differences in real-world health and economic outcomes among patients with COPD treated with combination tiotropium/olodaterol versus triple therapy. J Manag Care Spec Pharm 2020;26:1363-74.
DOI: https://doi.org/10.18553/jmcp.2020.20159
Rabe KF, Martinez FJ, Ferguson GT, et al. Triple inhaled therapy at two glucocorticoid doses in moderate-to-very-severe COPD. N Engl J Med 2020;383:35-48.
DOI: https://doi.org/10.1056/NEJMoa1916046
How to Cite
Deshmukh, Kartik, and Arjun Khanna. 2021. “Single Inhaler Triple Therapy in COPD – All That Glitters Is Not Gold”. Monaldi Archives for Chest Disease 91 (2). https://doi.org/10.4081/monaldi.2021.1617.
Copyright (c) 2021 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Evgenia I. Kalamara, Evangelos T. Ballas, Georgia Pitsiou, Guergana Petrova, Pulmonary rehabilitation for cystic fibrosis: A narrative review of current literature , Monaldi Archives for Chest Disease: Vol. 91 No. 2 (2021)
- Kashyap Goyal, Subodh Kumar, Mayank Mishra, Ritisha Bhatt, Adabala Vijay Babu, Mukesh Tripathi, A malignant wheeze! , Monaldi Archives for Chest Disease: Vol. 88 No. 3 (2018)
- Lorenzo Palleschi, Eleonora Nunziata, Net clinical benefit of anticoagulation therapy in the elderly patients with atrial fibrillation , Monaldi Archives for Chest Disease: Vol. 88 No. 2 (2018)
- Marika Werren, Roberto Copetti, Nicola Gaibazzi, Franco Giada, Andrea Faggiano, Chiara Ricci, Pompilio Faggiano, Choosing wisely in cardiology: Five proposals from the Italian Association for Cardiovascular Prevention and Rehabilitation , Monaldi Archives for Chest Disease: Vol. 89 No. 2 (2019)
- J.A. Gullón, I. Suárez, M. Lecuona, R. Fernández, G. Rubinos, A. Medina, C. Cabrera, I. González, Time to culture conversion in smokers with pulmonary tuberculosis , Monaldi Archives for Chest Disease: Vol. 71 No. 3 (2009): Pulmonary series
- Gianluigi Balestroni, Pantaleo Giannuzzi, Patient’s emotional reactions in cardiac rehabilitation: analysis and perspectives , Monaldi Archives for Chest Disease: Vol. 74 No. 1 (2010): Cardiac series
- Sabino Scardi, Pierpaolo Gori, Paolo Umari, Nurse involment in primary care: it is the key to improve the outcomes in primary and secondary prevention? , Monaldi Archives for Chest Disease: Vol. 74 No. 2 (2010): Cardiac series
- Gerson Cipriano Jr, Graziella França Bernardelli, Ross Arena, Luis Vicente Franco Oliveira, Francisco Valdez, João Nelson Rodrigues Branco, Cardio-respiratory responses of the 6-minute walk test in patients with refractory heart failure during the preoperative period for heart transplant surgery , Monaldi Archives for Chest Disease: Vol. 74 No. 2 (2010): Cardiac series
- Antonio Cittadini, Eduardo Bossone, Alberto Maria Marra, Michele Arcopinto, Emanuele Bobbio, Salvatore Longobardi, Carmine Cevara, Sara Di Michele, Luigi Saccà , Anabolic/Catabolic Imbalance in Chronic Heart Failure , Monaldi Archives for Chest Disease: Vol. 74 No. 2 (2010): Cardiac series
- Filippo M. Sarullo, Luigi Americo, Antonino Di Franco, Pietro Di Pasquale, Rhabdomyolysis induced by co-administration of fluvastatin and colchicine , Monaldi Archives for Chest Disease: Vol. 74 No. 3 (2010): Cardiac series
<< < 40 41 42 43 44 45 46 47 48 49 > >>
You may also start an advanced similarity search for this article.
